Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Carcinoma, Hepatocellular/etiology"'
INTRODUÇÃO: O carcinoma hepatocelular (CHC) é o mais frequente tipo de câncer primário do fígado e a sua incidência vem aumentando nas últimas décadas, tornando-o hoje a terceira causa de morte por câncer no mundo. Em cerca de 70 a 80% dos
Autor:
Cuba, Jefferson Wrublack, Anjos, Amanda da Silva, Toderke, Edimar Leandro, Kwiatkowski, Filipe Vieira
Publikováno v:
Revista Brasileira de Cancerologia; Vol. 67 No. 2 (2021): Apr./May/June; e-121220
Revista Brasileira de Cancerologia; Vol. 67 Núm. 2 (2021): abr./mayo/jun.; e-121220
Revista Brasileira de Cancerologia; v. 67 n. 2 (2021): abr./maio/jun.; e-121220
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
Revista Brasileira de Cancerologia; Vol. 67 Núm. 2 (2021): abr./mayo/jun.; e-121220
Revista Brasileira de Cancerologia; v. 67 n. 2 (2021): abr./maio/jun.; e-121220
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
Introduction: Hepatitis C is associated with the development of hepatocellular carcinoma (HCC). The interferon-based therapeutic regimen has been replaced by direct-acting antivirals (AAD) to treat HCV virus infection. However, recent studies have sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::6899ab7d9a84346a560834b9f4b07f39
https://rbc.inca.gov.br/index.php/revista/article/view/1220
https://rbc.inca.gov.br/index.php/revista/article/view/1220
Autor:
Evangelista, Andréia Silva
A doença hepática associada a sobrecarga de ferro pode ocorrer devido a causas genéticas ou secundárias. Esse estudo avaliou pacientes com hepatopatia crônica com sobrecarga de ferro submetidos à pesquisa das mutações HFE no período de 2007-
Congenital portosystemic shunts (CPSS) are a rare vascular consequence of embryogenetic vascular alterations or the persistence of the fetal circulation elements, first described by John Abernethy in 1793 and classified by Morgan and Superina, into c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2340::a3daab51f46e6880479fb11fc04a2058
https://hdl.handle.net/10400.17/4065
https://hdl.handle.net/10400.17/4065
Autor:
Gaviria-Calle, Marcela, Duque-Jaramillo, Alejandra, Aranzazu, Mateo, Filippo, Diana di, Montoya, Melissa, Roldán, Ingrid, Palacio, Natalia, Jaramillo, Sergio, Restrepo, Juan Carlos, Hoyos, Sergio, Navas, María-Cristina
Publikováno v:
Biomédica: revista del Instituto Nacional de Salud, Vol 38, Iss 4, Pp 555-568 (2018)
Biomédica, Volume: 38, Issue: 4, Pages: 555-568, Published: DEC 2018
Biomédica, Volume: 38, Issue: 4, Pages: 555-568, Published: DEC 2018
Resumen Introducción. Uno de los principales factores de riesgo del carcinoma hepatocelular es el consumo crónico de alcohol. En estudios en diferentes poblaciones, se sugiere que las variantes genéticas de las enzimas que participan en el metabol
Autor:
Rocio Lopez, Pierre Hainaut, Iris Suarez M, Germán Osorio, Pascal Pineau, Diego Uribe, Sergio Hoyos, Juan Camilo Pérez, Maria-C Navas, Carlos Mario Jaramillo
Publikováno v:
Annals of hepatology : official journal of the Mexican Association of Hepatology
Annals of hepatology : official journal of the Mexican Association of Hepatology, Elsevier, 2015, 14 (1), pp.64-74. ⟨10.1016/S1665-2681(19)30802-6⟩
Annals of Hepatology, Vol 14, Iss 1, Pp 64-74 (2015)
Annals of hepatology : official journal of the Mexican Association of Hepatology, 2015, 14 (1), pp.64-74. ⟨10.1016/S1665-2681(19)30802-6⟩
Annals of hepatology : official journal of the Mexican Association of Hepatology, Elsevier, 2015, 14 (1), pp.64-74. ⟨10.1016/S1665-2681(19)30802-6⟩
Annals of Hepatology, Vol 14, Iss 1, Pp 64-74 (2015)
Annals of hepatology : official journal of the Mexican Association of Hepatology, 2015, 14 (1), pp.64-74. ⟨10.1016/S1665-2681(19)30802-6⟩
International audience; Background and aim. Hepatocellular carcinoma (HCC) is the most common primary liver cancer diagnosed worldwide. Deregulation of Wnt/β-catenin pathway has been associated with the development of HCC in a substantial number of
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
INTRODUÇÃO: O carcinoma hepatocelular (CHC) é o mais frequente tipo de câncer primário do fígado e a sua incidência vem aumentando nas últimas décadas,tornando-o hoje a terceira causa de morte por câncer no mundo. Em cerca de 70 a 80% dos p
Autor:
Mikolašević, Ivana, Orlić, Lidija, Štimac, Davor, Mavrinac, Vojko, Ferenčić, Antun, Rundić, Anamarija, Babić, Vesna, Milić, Sandra
Publikováno v:
Liječnički vjesnik
Volume 138
Issue 11-12
Volume 138
Issue 11-12
S porastom incidencije debljine i metaboličkog sindroma raste i incidencija nealkoholne masne bolesti jetre (engl. nonalcoholic fatty liver disease – NAFLD). Osim što ovi bolesnici imaju znatan rizik od progresije u terminalni stadij kronične bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5d29e0b21d59abcf29ae2016658be55c
https://urn.nsk.hr/urn:nbn:hr:184:133421
https://urn.nsk.hr/urn:nbn:hr:184:133421
Autor:
Mikolašević, Ivana, Orlić, Lidija, Štimac, Davor, Mavrinac, Vojko, Colić, Marina, Ostojić, Daniela, Milić, Sandra
Publikováno v:
Liječnički vjesnik
Volume 138
Issue 5-6
Volume 138
Issue 5-6
Nealkoholna masna bolest jetre (engl. nonalcoholic fatty liver disease – NAFLD) čest je uzrok aletiranih jetrenih parametara. Povezanost između masne jetre i metaboličkog sindroma (MS) dobro je dokumentirana i široko prihvaćena. Ciroza kao pos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::76e5d1351731be2c27334ac6cd235d9a
https://www.bib.irb.hr/812428
https://www.bib.irb.hr/812428
Autor:
Ivana Mikolašević, Lidija Orlić, Davor Štimac, Vojko Mavrinac, Antun Ferenčić, Anamarija Rundić, Vesna Babić, Sandra Milić
Publikováno v:
Liječnički vjesnik
Volume 138
Issue 11-12
Volume 138
Issue 11-12
S porastom incidencije debljine i metaboličkog sindroma raste i incidencija nealkoholne masne bolesti jetre (engl. nonalcoholic fatty liver disease – NAFLD). Osim što ovi bolesnici imaju znatan rizik od progresije u terminalni stadij kronične bo